郭明錤:苹果明年或推MR耳机 2030年推AR隐形眼镜
天风国际分析师郭明錤发表报告,预测苹果(AAPL.US)将在明年中发布混合实境(Mixed Reality, MR)耳机,然後在2025年前发布扩增实境(Augmented Reality, AR)眼镜。
报告提到,苹果将分3个阶段推出MR及AR产品,明年会推出头戴类型产品,到2025年则会轮到眼镜类型,而最快在2030年推出隐形眼镜类型。
郭明錤表示,目前苹果的MR头戴式耳机的多个原型模组重量为200至300克,但如果苹果能够解决技术问题,最终重量将减少到100至200克,由於设计复杂,预计这款耳机在美国的售价约为1,000美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.